Gbinigie II and Lasserson D |
Clarithromycin-induced akathisia: a class effect of macrolides? |
2016 |
BMJ Case Rep |
pmid:27927708
|
Miftahussurur M et al. |
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations. |
2016 |
PLoS ONE |
pmid:27906990
|
Velu PP et al. |
Pulmonary Mycobacterium marinum infection: 'fish tank granuloma' of the lung. |
2016 |
Scott Med J |
pmid:27872397
|
Noh HM et al. |
Eradication Rate by Duration of Third-line Rescue Therapy with Levofloxacin after Helicobacter pylori Treatment Failure in Clinical Practice. |
2016 |
Korean J Gastroenterol |
pmid:27871162
|
Yazdanbakhsh AR et al. |
Reduction of non-Betalactam Antibiotics COD by Combined Coagulation and Advanced Oxidation Processes. |
2016 |
Water Environ. Res. |
pmid:28661328
|
Noda H et al. |
A Novel Potassium-Competitive Acid Blocker Improves the Efficacy of Clarithromycin-containing 7-day Triple Therapy against Helicobacter pylori. |
2016 |
J Gastrointestin Liver Dis |
pmid:27689190
|
Giorgio F et al. |
Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis. |
2016 |
Scand. J. Gastroenterol. |
pmid:27687850
|
Donzelli A |
Helicobacter pylori Eradication? |
2016 |
Gastroenterology |
pmid:27590693
|
Sanches BS et al. |
Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey. |
2016 |
World J. Gastroenterol. |
pmid:27672279
|
Ohe M et al. |
A case of lupus nephritis treated with clarithromycin, tacrolimus, and glucocorticoids. |
2016 |
Kaohsiung J. Med. Sci. |
pmid:27638410
|
Cosme A et al. |
Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance. |
2016 |
Helicobacter |
pmid:25982426
|
Luo XF et al. |
Establishment of a nested-ASP-PCR method to determine the clarithromycin resistance of Helicobacter pylori. |
2016 |
World J. Gastroenterol. |
pmid:27433095
|
Sakurai Y et al. |
Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study. |
2016 |
Adv Ther |
pmid:27432383
|
Inagaki K et al. |
Successful Treatment of Peritoneal Dialysis-related Peritonitis due to Mycobacterium iranicum. |
2016 |
Intern. Med. |
pmid:27432106
|
Shiratori S et al. |
Two Cases of Chronic Gastritis with non-Helicobacter pylori Helicobacter Infection. |
2016 |
Intern. Med. |
pmid:27432094
|
Furuta K et al. |
18 Cases of pulmonary Mycobacterium abscessus: Clinical difference depending on the presence or absence of Mycobacterium avium complex. |
2016 |
J. Infect. Chemother. |
pmid:27430867
|
Zemali N et al. |
Helicobacter pylori resistance to clarithromycin in Reunion Island. |
2016 |
Med Mal Infect |
pmid:27427280
|
Ozeki K et al. |
Association of Hay Fever with the Failure of Helicobacter pylori Primary Eradication. |
2016 |
Intern. Med. |
pmid:27374672
|
Campillo A et al. |
[Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection]. |
2016 |
Med Clin (Barc) |
pmid:27374029
|
Hirasawa K et al. |
Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines. |
2016 |
PLoS ONE |
pmid:27977675
|
Mougari F et al. |
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27690688
|
Phiphatpatthamaamphan K et al. |
Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study. |
2016 |
Asian Pac. J. Cancer Prev. |
pmid:27221874
|
Kim SY et al. |
Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report. |
2016 |
BMC Infect. Dis. |
pmid:27188784
|
Suzuki S et al. |
The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy. |
2016 |
Am. J. Gastroenterol. |
pmid:27185079
|
Garcia de Carvalho NF et al. |
Resazurin Microtiter Assay for Clarithromycin Susceptibility Testing of Clinical Isolates of Mycobacterium abscessus Group. |
2016 |
J. Clin. Lab. Anal. |
pmid:27169515
|
Schuster S et al. |
Evidence of a Substrate-Discriminating Entrance Channel in the Lower Porter Domain of the Multidrug Resistance Efflux Pump AcrB. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27161641
|
Oberhofer E |
[Quadruple therapy is more effective against H. pylori]. |
2016 |
MMW Fortschr Med |
pmid:27155683
|
Li M et al. |
Inducible Expression of both ermB and ermT Conferred High Macrolide Resistance in Streptococcus gallolyticus subsp. pasteurianus Isolates in China. |
2016 |
Int J Mol Sci |
pmid:27669217
|
Klesiewicz K et al. |
Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone. |
2016 |
J. Antibiot. |
pmid:27025351
|
Kawashima K et al. |
Successful eradication of Helicobacter pylori infection with vonoprazan-based triple therapy after failure of PPI-based triple therapy. |
2016 |
Dig Liver Dis |
pmid:27012448
|
Ormeci A et al. |
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:27010145
|
Dubini M et al. |
Multiple drug allergy: A case of anaphylaxis to levofloxacin but tolerance to ciprofloxacin. |
2016 |
Ann. Allergy Asthma Immunol. |
pmid:27009438
|
Miyashita N et al. |
Macrolide Therapy for Prevention of Exacerbation in Individuals with Diffuse Aspiration Bronchiolitis. |
2016 |
J Am Geriatr Soc |
pmid:27000351
|
Shichijo S et al. |
Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. |
2016 |
Gastrointest. Endosc. |
pmid:26995689
|
Radzikowska E et al. |
Cryptogenic Organizing Pneumonia: IL-1β, IL-6, IL-8, and TGF- β1 Serum Concentrations and Response to Clarithromycin Treatment. |
2016 |
Adv. Exp. Med. Biol. |
pmid:26987326
|
Wu DC et al. |
A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection. |
2016 |
Medicine (Baltimore) |
pmid:26986096
|
Swaminathan A et al. |
Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications. |
2016 |
Int. J. Tuberc. Lung Dis. |
pmid:26970156
|
Wong IC |
Author's reply to Blake. |
2016 |
BMJ |
pmid:26957514
|
Bohnert JA et al. |
Novel Piperazine Arylideneimidazolones Inhibit the AcrAB-TolC Pump in Escherichia coli and Simultaneously Act as Fluorescent Membrane Probes in a Combined Real-Time Influx and Efflux Assay. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26824939
|
Kadota T et al. |
Analysis of drug treatment outcome in clarithromycin-resistant Mycobacterium avium complex lung disease. |
2016 |
BMC Infect. Dis. |
pmid:26818764
|
Gaüzère BA and Malvy D |
[Vingt-cinquième réunion du comité local de la Société de pathologie exotique, 24 novembre 2015]. |
2016 |
Bull Soc Pathol Exot |
pmid:26818816
|
Tebruegge M et al. |
Nontuberculous Mycobacterial Disease in Children - Epidemiology, Diagnosis & Management at a Tertiary Center. |
2016 |
PLoS ONE |
pmid:26812154
|
Fralick M et al. |
Bleeding associated with coadministration of rivaroxaban and clarithromycin. |
2016 |
CMAJ |
pmid:26811362
|
Berlin S et al. |
Pharmacokinetics and Pulmonary Distribution of Clarithromycin and Rifampicin after Concomitant and Consecutive Administration in Foals. |
2016 |
Mol. Pharm. |
pmid:26808255
|
Sun H et al. |
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014]. |
2016 |
Zhonghua Jie He He Hu Xi Za Zhi |
pmid:26792053
|
Topp E et al. |
Reduced persistence of the macrolide antibiotics erythromycin, clarithromycin and azithromycin in agricultural soil following several years of exposure in the field. |
2016 |
Sci. Total Environ. |
pmid:27096634
|
Li X et al. |
Macrolides use and the risk of sudden cardiac death. |
2016 |
Expert Rev Anti Infect Ther |
pmid:27086751
|
Boyanova L et al. |
Clarithromycin Resistance Mutations in Helicobacter pylori in Association with Virulence Factors and Antibiotic Susceptibility of the Strains. |
2016 |
Microb. Drug Resist. |
pmid:26618567
|
Villain J et al. |
Acute toxicities of pharmaceuticals toward green algae. mode of action, biopharmaceutical drug disposition classification system and quantile regression models. |
2016 |
Ecotoxicol. Environ. Saf. |
pmid:26590695
|
Geng S et al. |
Clarithromycin ion pair in a liposomal membrane to improve its stability and reduce its irritation caused by intravenous administration. |
2016 |
Expert Opin Drug Deliv |
pmid:26588710
|
Eszik I et al. |
High dynamic range detection of Chlamydia trachomatis growth by direct quantitative PCR of the infected cells. |
2016 |
J. Microbiol. Methods |
pmid:26578244
|
Chen CH et al. |
Mycobacterium abscessus complex bacteremia due to prostatitis after prostate biopsy. |
2016 |
Indian J Tuberc |
pmid:27998503
|
Shin WG et al. |
Eradication Rates of Helicobacter pylori in Korea Over the Past 10 years and Correlation of the Amount of Antibiotics Use: Nationwide Survey. |
2016 |
Helicobacter |
pmid:26470999
|
Cerqueira RM et al. |
How Effective Is the Quadruple Concomitant Helicobacter Pylori Eradication Therapy for Obese Patients Undergoing Gastric Bypass Surgery? |
2016 |
Obes Surg |
pmid:26467690
|
Boyanova L et al. |
Helicobacter pylori resistance to six antibiotics by two breakpoint systems and resistance evolution in Bulgaria. |
2016 |
Infect Dis (Lond) |
pmid:26465202
|
Lahmer T et al. |
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS. |
2016 |
Mycopathologia |
pmid:26455910
|
Katayama Y et al. |
Neuroprotective effects of clarithromycin against neuronal damage in cerebral ischemia and in cultured neuronal cells after oxygen-glucose deprivation. |
2017 |
Life Sci. |
pmid:27825902
|
Moj D et al. |
Clarithromycin, Midazolam, and Digoxin: Application of PBPK Modeling to Gain New Insights into Drug-Drug Interactions and Co-medication Regimens. |
2017 |
AAPS J |
pmid:27822600
|
Akpinar Z et al. |
Improving the standard sequential treatment of Helicobacter pylori with either extended treatment or by adding bismuth. |
2017 |
Arab J Gastroenterol |
pmid:28532623
|
Beckman E et al. |
A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate. |
2017 |
J. Clin. Microbiol. |
pmid:28515219
|
Kajihara Y et al. |
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication. |
2017 |
Scand. J. Gastroenterol. |
pmid:27806639
|
Yan J et al. |
Survey about the use of clarithromycin in an ENT outpatient department of a tertiary hospital. |
2017 |
Eur Arch Otorhinolaryngol |
pmid:28508178
|
Shaulov A et al. |
Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. |
2017 |
Am. J. Hematol. |
pmid:27804150
|
DaCosta A et al. |
Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients. |
2017 |
J. Cyst. Fibros. |
pmid:28495380
|
Malfertheiner P et al. |
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. |
2017 |
Gut |
pmid:27707777
|
Sharifi R et al. |
Dietary PUFA Increase Apoptosis in Stomach of Patients with Dyspeptic Symptoms and Infected with H. pylori. |
2017 |
Lipids |
pmid:28493185
|
Reddy AB and Reddy ND |
Development of Multiple-Unit Floating Drug Delivery System of Clarithromycin: Formulation, in vitro Dissolution by Modified Dissolution Apparatus, in vivo Radiographic Studies in Human Volunteers. |
2017 |
Drug Res (Stuttg) |
pmid:28449156
|
Aktas AH and Saridag AM |
Liquid Chromatographic-Chemometric Techniques for the Simultaneous HPLC Determination of Lansoprazole, Amoxicillin and Clarithromycin in Commercial Preparation. |
2017 |
J Chromatogr Sci |
pmid:28449104
|
Itskoviz D et al. |
Smoking increases the likelihood of Helicobacter pylori treatment failure. |
2017 |
Dig Liver Dis |
pmid:28427781
|
Koštrun S et al. |
Around the macrolide - Impact of 3D structure of macrocycles on lipophilicity and cellular accumulation. |
2017 |
Eur J Med Chem |
pmid:28410508
|
Giguère S et al. |
Antimicrobial Resistance in . |
2017 |
Microbiol Spectr |
pmid:29052538
|
Giguère S |
Treatment of Infections Caused by Rhodococcus equi. |
2017 |
Vet. Clin. North Am. Equine Pract. |
pmid:28161038
|
Berni E et al. |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. |
2017 |
BMJ Open |
pmid:28115334
|
Yatera K et al. |
The additive effect of clarithromycin on influenza A infection in the elderly patients and patients with comorbid diseases. |
2017 |
Respir Investig |
pmid:29153420
|
Lee MC et al. |
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan. |
2017 |
J. Antimicrob. Chemother. |
pmid:29091186
|
Costa S et al. |
Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection. |
2017 |
Eur J Gastroenterol Hepatol |
pmid:28877088
|
Pryjma M et al. |
Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the Gene. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28874379
|
Takahashi C et al. |
Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease. |
2017 |
Med Mol Morphol |
pmid:27119723
|
Laidler N |
Cutaneous infection with paucibacillary treated successfully with a modified antituberculous drug regimen. |
2017 |
BMJ Case Rep |
pmid:29275384
|
Lee JS et al. |
Implication of species change of Nontuberculous Mycobacteria during or after treatment. |
2017 |
BMC Pulm Med |
pmid:29262802
|
Ruiter R et al. |
Helicobacter pylori resistance in the Netherlands: a growing problem? |
2017 |
Neth J Med |
pmid:29219812
|
Tsay FW et al. |
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28807915
|
Oh ES et al. |
Effects of clarithromycin on the pharmacokinetics of evogliptin in healthy volunteers. |
2017 |
J Clin Pharm Ther |
pmid:28806472
|
Kuo YT et al. |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis. |
2017 |
Lancet Gastroenterol Hepatol |
pmid:28781119
|
Ramas M et al. |
Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial. |
2017 |
Gastroenterol Hepatol |
pmid:28780968
|
Painsi C and Lange-Asschenfeldt B |
Image Gallery: Pink papules within a tattoo linked to Mycobacterium chelonae infection. |
2017 |
Br. J. Dermatol. |
pmid:28731256
|
Mougari F et al. |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies. |
2017 |
Antimicrob. Agents Chemother. |
pmid:27799212
|
Hu Y et al. |
Novel and Effective Therapeutic Regimens for in an Era of Increasing Antibiotic Resistance. |
2017 |
Front Cell Infect Microbiol |
pmid:28529929
|
Jeong SH et al. |
Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections. |
2017 |
Int. J. Infect. Dis. |
pmid:28522316
|
Kishida D et al. |
Intractable Cutaneous Nontuberculous Mycobacteriosis (Mycobacterium abscessus) during Treatment for Systemic Lupus Erythematosus. |
2017 |
Intern. Med. |
pmid:28502947
|
Jung YS et al. |
Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication. |
2017 |
Aliment. Pharmacol. Ther. |
pmid:28497487
|
Sharman MJ et al. |
Gastrokine mRNA expression in gastric tissue from dogs with helicobacter colonisation but without inflammatory change during treatment. |
2017 |
Vet. Immunol. Immunopathol. |
pmid:28494926
|
O'Brien CR et al. |
Feline leprosy due to Candidatus 'Mycobacterium tarwinense':Further clinical and molecular characterisation of 15 previously reported cases and an additional 27 cases |
2017 |
J. Feline Med. Surg. |
pmid:28438086
|
Tan B et al. |
Polaprezinc combined with clarithromycin-based triple therapy for Helicobacter pylori-associated gastritis: A prospective, multicenter, randomized clinical trial. |
2017 |
PLoS ONE |
pmid:28407007
|
Kristin F et al. |
Dissolution and dissolution/permeation experiments for predicting systemic exposure following oral administration of the BCS class II drug clarithromycin. |
2017 |
Eur J Pharm Sci |
pmid:28179133
|
Chen D et al. |
Phenotypic and Molecular Antimicrobial Susceptibility of Helicobacter pylori. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28167563
|
Olesen JS et al. |
Mycobacterium chelonae hand infection after steroid injection in a patient with rheumatoid arthritis receiving long-term linezolid therapy. |
2017 |
BMJ Case Rep |
pmid:28137898
|
Chang JY et al. |
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication. |
2017 |
BMC Gastroenterol |
pmid:28109257
|
Sasaoka Y et al. |
Neonatal apnea with Chlamydia pneumoniae infection. |
2017 |
Pediatr Int |
pmid:28102626
|
Lapa GB et al. |
Two approaches to the use of benzo[c][1,2]oxaboroles as active fragments for synthetic transformation of clarithromycin. |
2017 |
J Enzyme Inhib Med Chem |
pmid:28097898
|